The pharmaceutical water market will grow at the highest pace owing to increasing adoption of AI in water treatment. The pharmaceutical water market involves water treated specially to meet stringent quality standards required for the production of drugs, medical devices and equipment. Pharmaceutical grade water is purified and deionized to extremely low levels of impurities using various filtration processes including reverse osmosis, ion exchange, UV oxidation etc. It is a crucial requirement in manufacturing processes to ensure product safety, efficacy and purity.

The global pharmaceutical water market is estimated to be valued at US$ 7.22 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the pharmaceutical water market are Heidelberg Printing Machinery AG,Komori Corporation,Koenig & Bauer AG,Manroland Goss web systems,HP Inc.,Xerox Corporation,Canon Inc.,Ricoh Company, Ltd.,Epson,Konica Minolta, Inc. The increasing penetration of these players across major pharma manufacturing hubs is fueling market growth.

Growing generics market and new drug approvals are major factors boosting the Pharmaceutical Water Market Size. The rising production of generic drugs, biologics and vaccines requires larger volumes of high purity water produced under stringent quality standards.

Technological advancements in water purification systems focused on Industry 4.0 solutions are enabling real-time monitoring, predictive maintenance and automation in water treatment processes. Growing adoption of IoT and AI is helping optimize water usage, reduce operational costs and improve process efficiency in pharma plants.

Market Trends

Growing focus on developing continuous and modular water treatment systems aligned with pharmaceutical production workflows gaining traction. Continuous systems can support consistent water production at high volumes with minimal downtime.

Increasing R&D into alternative purification technologies such as conductive porous materials, forward osmosis and ion diffusion to develop cost-effective and sustainable solutions for producing high purity water.

Market Opportunities

Emerging markets in Asia Pacific and Latin America expected to provide huge opportunities for pharma water system vendors driven by expansion of domestic pharma production capacity.

Adoption of advanced solutions such as pre-treatment technology, ultrafiltration and electrodeionization expected to gather pace as pharmaceutical companies focus on achieving Zero Liquid Discharge.

Impact of COVID-19 on Pharmaceutical Water Market

The COVID-19 pandemic has significantly impacted the growth of the pharmaceutical water market globally. The demand for pure and high-quality water in the pharmaceutical industry increased substantially during the pandemic. Stringent regulations regarding the production of pure drugs and medicines amplified the need for advanced water treatment systems. The investments in R&D for vaccine and drug development also fueled the adoption of various water treatment solutions across pharmaceutical manufacturing facilities.

The pre-COVID market was growing steadily at a CAGR of around 8-9% driven majorly by the expansion of pharmaceutical production capacities across emerging nations. However, during the pandemic, the growth accelerated to over 11% annually owing to robust demand from biopharma companies working towards developing COVID-19 therapeutics and vaccines. factors as stringent environmental norms regarding wastewater discharge from pharma plants further propelled the demand. Even post pandemic, the market is expected to maintain double-digit growth on the back of sustained investments in pharmaceutical infrastructure and capacity enhancements worldwide. New technologies focused on energy-efficient water treatment are likely to get more traction.

In terms of geographical distribution of value, North America dominated the pharmaceutical water market prior to the pandemic owing to presence of largest pharmaceutical producers and stringent regulatory oversight. However, Asia Pacific registered fastest gains during COVID-19 due to expansions undertaken by leading vaccine developers in India and China to augment supplies. Emerging nations also received significant investments to boost local drug manufacturing capabilities. Going forward, Asia Pacific is predicted to be the fastest growing regional market.

Europe has traditionally been the second largest pharmaceutical water market supported by large pharmaceutical production base and strict environmental norms. The geographical demand remained robust throughout the pandemic. Countries like Germany and UK are anticipated to continue dominating the European market because of concentration of major pharmaceutical players.

Get more insights on Pharmaceutical Water Market

Leave a Reply

Your email address will not be published. Required fields are marked *